Skip to main content
Premium Trial:

Request an Annual Quote

Sanger Builds Sequencing Management Team; Kendrick-Parker Joins GenTel’s Board, Rowe Joins Gene Express, and Others

NEW YORK (GenomeWeb News) - The Wellcome Trust Sanger Institute has made a number of changes in its sequencing management team. Julian Parkhill has been appointed director of sequencing, Carol Churcher has been named head of sequencing operations, and Harold Swerdlow is now head of sequencing technology.
 
Parkhill was previously head of the pathogen sequencing unit at the Sanger Institute. As director of sequencing, his role will be to “support the new management team, to give strategic direction, and to promote the important interactions between the institute’s faculty investigators and the sequencing group,” Sanger said in a statement.
 
Churcher has been on the Sanger staff since the institute was founded in 1993 and is a senior manager in the pathogen sequencing unit. Previously, she worked at the MRC Laboratory of Molecular Biology.
 
Swerdlow was most recently senior director of research at Solexa, which was acquired by Illumina last year.
 
Jane Rogers, who was previously head of sequencing at the institute, left last year, according to a Sanger spokesperson.
 

 
Chris Kendrick-Parker has joined the board of directors at GenTel Biosciences.
 
Kendrick-Parker was at Affymetrix for nine years, where he was VP of sales and marketing in the global pharma business unit, and was also responsible for market development.
 
He also worked in the department of human oncology at the University of Wisconsin Comprehensive Cancer Center and at Amersham Pharmacia.
 

 
Cellzome has appointed Jane Dancer as vice president of business development. Dancer formerly was director of business development at MedImmune, where she was involved in in-licensing and out-licensing activities. Dancer also was a global project manager at Aventis Crop Science and was a team leader at Schering Agrochemicals and at AgroEveo UK.
 

 
Jonathan Rowe will take over the role of senior VP of strategy and clinical innovation at Gene Express, the company said this week.
 
Rowe has worked at Pfizer as a senior director of worldwide pharmaceutical sciences, director of intellectual property strategy management, and clinical director of the cardiovascular risk factors group.
 
Rowe has also served as a scientific advisor for the law firm Kaye, Scholer, where he was involved in IP litigation for biotechnology and pharmaceutical firms.
 

 
GeneNews has appointed three new members to its Colorectal Cancer Clinical Advisory Board: David Lieberman, David SIdransky, and Richard Wender.
 
Lieberman is a professor of medicine and chief of gastroenterology at Oregon Health Sciences University and the Portland Veterans Affairs Medical Center. In 2007 he received the Laurel for Leadership from the Cancer Research and Prevention Foundation.
Sidransky is a director of the Head and Neck Cancer Research Program at the Sidney Kimmel Comprehensive Cancer Center, as well as a professor of oncology, cellular and molecular medicine and genetics, and other specialties at the Johns Hopkins University School of Medicine. He received the 2004 Hinda Rosenthal Award from the American Association of Cancer Research.
 
Wender is chair of the department of family and community medicine at Thomas Jefferson University in Philadelphia and he has served on the steering committee of the National Colorectal Cancer Roundtable and worked with the US Centers for Disease Control and Prevention to develop a training program aimed at colorectal cancer prevention and screening.
 

 
Chris Kendrick-Parker has joined the board of directors at GenTel Biosciences.
 
Kendrick-Parker was at Affymetrix for nine years, where he was VP of sales and marketing in the global pharma business unit, and was also responsible for market development.
 
He also worked in the department of human oncology at the University of Wisconsin Comprehensive Cancer Center and at Amersham Pharmacia.
 

 
Jonathan Gitlin, currently chief of genetics and genomic medicine at St. Louis Children’s Hospital will take over as chair of the department of pediatrics at the Monroe Carell Jr. Children’s Hospital at Vanderbilt University. Gitlin will begin the new post in June.
 

 
Proteomics researcher Edward Marcotte of the University of Texas at Austin has been awarded the 2008 Edith and Peter O’Donnell Award from the Academy of Medicine, Engineering and Science of Texas.
 
Marcotte, who focuses on mapping protein interactions in a wide range of organisms, is co-director of the Center for Systems and Synthetic Biology.
 

 
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in PEOPLE, a weekly roundup of industry comings and goings.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.